3.
Variables | n | 5-YSR (%) | P |
5-YSR, 5-year survival rates; UICC, Union for International Cancer Control; eLN, examined lymph nodes; NLN, number of retrieved negative lymph nodes; MLR, metastatic lymph node ratio; LODDS, log odds of positive lymph nodes. | |||
6th UICC N-stage | <0.0001 | ||
N0 | 67 | 74.3 | |
N1 | 66 | 49.3 | |
N2 | 27 | 18.5 | |
N3 | 4 | 0 | |
7th UICC N-stage | <0.0001 | ||
N0 | 67 | 74.3 | |
N1 | 33 | 52.1 | |
N2 | 33 | 47.7 | |
N3 | 31 | 19.0 | |
8th UICC N-stage | <0.0001 | ||
N0 | 67 | 74.3 | |
N1 | 33 | 52.1 | |
N2 | 33 | 47.7 | |
N3a | 27 | 18.5 | |
N3b | 4 | N/A | |
eLN | 0.581 | ||
<16 | 127 | 54.2 | |
≥16 | 37 | 60.0 | |
NLN | 0.209 | ||
0–9 | 117 | 52.2 | |
10–14 | 24 | 52.3 | |
≥15 | 23 | 73.1 | |
MLR (%) | <0.0001 | ||
0 | 67 | 74.3 | |
0.1–20.0 | 19 | 54.2 | |
20.1–50.0 | 30 | 47.1 | |
≥50.1 | 48 | 30.0 | |
LODDS | <0.0001 | ||
< –1.125 | 29 | 81.9 | |
–1.125 – –0.251 | 75 | 64.7 | |
–0.250 – 0.749 | 43 | 31.0 | |
≥0.750 | 17 | 0 |